With more than 13,000 actively monitored patients, Cadence data highlights how various patient subgroups experienced significantly improved clinical outcomes and a sizeable reduction in total cost of care
NEW YORK–(BUSINESS WIRE)–Today, Cadence, a health technology company partnered with eight leading health systems across the U.S., unveiled its inaugural Outcomes Report. The report finds that an advanced practice provider-led remote patient monitoring (RPM) program with proven treatment protocols provides a scalable solution for chronic care management nationwide.
The data shows Cadence’s remote monitoring solution is a win-win-win that: Positively impacts patient outcomes and leads to more effective primary care for chronic disease patients; reduces healthcare costs for patients, hospital systems, and the U.S. healthcare system at large; and helps physicians deliver better clinical care while also saving them time and alleviating burden.
Positive impact on patient outcomes
In partnership with leading academic medical centers and health systems in the U.S., Cadence has built a virtual heart failure clinic, virtual diabetes clinic, and virtual hypertension clinic that deliver guideline-directed care to patients 24/7 and produce world-class outcomes. For example:
Lower cost of care
Across various analyses, Cadence patients also experienced a significant decrease in their total cost of care after enrollment. Examples include:
Time saving for clinicians
Cadence’s team of nurse practitioners, registered nurses, and clinical navigators act as an extension of physician practices. Using national guidelines and mutually agreed upon clinical protocols, the Cadence team titrates medications, orders labs, and provides education and lifestyle coaching to patients. The solution is helping physicians deliver better clinical care while also saving them time. For example:
Taken together, these results underscore the potential for broad-scale change by using RPM-powered virtual care to improve preventative care for patients with chronic disease.
“I am encouraged by how this solution is improving the delivery of care across our health system, our providers and patients,” said Dr. Lynn Simon, President, Healthcare Innovation & Chief Medical Officer at Community Health Systems. “These outcomes are a testament to the power that a provider-led, technology-enabled program like Cadence can have on addressing the challenges posed by chronic diseases in our communities.”
With 6 in 10 adults, or 130 million Americans, living with one or more chronic conditions, health systems, providers, and policymakers must collaborate to solve the accelerating impact of chronic disease in the U.S.
“What we need at this moment in healthcare are not just tools that can provide good clinical outcomes, but also those that are financially scalable and can help reduce the cost of care for patients,” said Aaron Lewis, executive vice president, growth and integrated solutions at Lifepoint Health. “The fact that Cadence has been proven to accomplish both of these goals is highly encouraging and highlights how remote monitoring technology can play a transformative role in primary care in the future.”
To read the full report, visit: https://www.cadence.care/outcomes-report-2023.
About Cadence
Cadence is a health technology company helping the nation’s most patient-centric health systems deliver more consistent, proactive healthcare every day. Cadence’s remote patient intervention solution couples powerful new technology with clinical excellence, providing its patients a precise and personal level of care, all outside of the four walls of the hospital. More information about the company can be found at www.cadence.care.
Contacts
Caitlyn Durcan, caitlyn@cadencerpm.com
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…
Montreal-based Thought Technology Ltd wraps up its 50th year in business providing psychophysiological instrumentation to…